Related Experiment Videos
[Injection therapy of the prostate in prostatic tuberculosis]
Der Urologe. Ausg. A
|January 1, 1975
Summary
Transcutaneous prostate injections effectively treat prostatic tuberculosis, achieving a 100% conversion rate in patients. This method offers a superior alternative to oral therapies for this challenging condition.
Area of Science:
- Urology
- Infectious Diseases
- Microbiology
Context:
- Prostatic tuberculosis (TB) presents a significant therapeutic challenge.
- Conventional oral anti-TB medications demonstrate limited efficacy, with conversion rates around 20%.
Purpose:
- To evaluate the efficacy and safety of transcutaneous prostate injections for treating prostatic tuberculosis.
Summary:
- A study involving 90 patients utilized transcutaneous prostate injections of Streptomycin (1g) and Isoniazid (INH) (0.1g) twice weekly for 4-5 weeks.
- This regimen achieved a 100% conversion rate in all treated patients.
- No complications contraindicating the treatment were observed.
Impact:
- Transcutaneous prostate injection therapy offers a highly effective treatment for prostatic TB.
- This minimally invasive approach is indicated for patients with urethrography-confirmed cavernous prostatic changes.
- The findings suggest a paradigm shift in managing prostatic tuberculosis.